Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Medexus Pharmaceuticals Inc (TSX: MDP )

2.430 +0.050 (+2.10%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Medexus Pharmaceuticals Inc

Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Medexus Expects Record Revenue for Fiscal Year 2023 and Provides Business Update
Annual revenue expected to exceed US$107 million for fiscal year ended March 31, 2023, an all-time record, including fiscal Q4 2023 revenue of at least US$28 million 
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Medexus Announces New License Deal for Topical Terbinafine
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Medexus Announces US$58.5 million in New Credit Facilities
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Medexus Pharmaceuticals Inc. (TSX: MDP) (OTCQX: MEDXF) Featured in Coverage of the 35th Annual Roth Conference
Via Investor Brand Network
Medexus to Participate in 35th Annual Roth Conference
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Medexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Medexus Welcomes Two New Board Members
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Medexus Secures Public Reimbursement for Cuvposa® in Quebec
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Medexus Schedules Third Fiscal Quarter 2023 Conference Call
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Medexus Expects Record Revenue for Fiscal Q3 2023 and Provides Business Update
Quarterly revenue expected to exceed US$28.5 million for quarter ended December 31, 2022, an all-time record 
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Medexus Announces Strongest Quarter in Company History with Fiscal Q2 2023 Revenue of US$27.7 Million, a 55% Increase Over Fiscal Q2 2022
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Medexus Schedules Second Quarter 2023 Conference Call
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Medexus Announces Preliminary Revenue Results for Second Fiscal Quarter 2023
Quarterly revenue expected to exceed US$27.0 million for quarter ended September 30, 2022, an all-time record 
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
Medexus and MidCap Agree to Increase in MidCap’s Revolving Loan Commitment Amount
From Medexus Pharmaceuticals Inc
Via GlobeNewswire
InvestorNewsBreaks – Nexstar Media Group Inc.’s (NASDAQ: NXST) Hartford-Based Station to Launch NEXTGEN TV
Via Investor Brand Network
Sidoti December Micro Cap Virtual Conference
Presentation Times Released for 75+ Presenting Companies Wednesday and Thursday, December 8-9, 2021 NEW YORK, NY / ACCESSWIRE / December 7, 2021 / Sidoti & Company, LLC has released the presentation... 
From Sidoti & Company, LLC
Via AccessWire
Medexus Pharmaceuticals to Present at the SNN Network Summer Virtual Event on Thursday, August 19, 2021
TORONTO, ON and CHICAGO, IL / ACCESSWIRE / August 10, 2021 / Medexus Pharmaceuticals Inc. (TSX:MDP) (OTCQX:MEDXF) today announced that it will be presenting at the SNN Network Summer Virtual Event 2021... 
From Medexus Pharmaceuticals Inc.
Via AccessWire
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021
LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be... 
From Stock News Now
Via AccessWire
Topics Cannabis
Exposures Cannabis
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CNST, MDP, FMBI, AVCO; Shareholders are Encouraged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / June 21, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Constellation Pharmaceuticals, Inc. (NASDAQ:CNST)... 
From Halper Sadeh LLP
Via AccessWire
Topics Fraud
Exposures Legal
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ONEM, QTS, EBSB, MDP; Shareholders are Encouraged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / June 15, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: 1Life Healthcare, Inc. (NASDAQ:ONEM) concerning... 
From Halper Sadeh LLP
Via AccessWire
Topics Fraud
Exposures Legal
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates EQT, MDP, EBSB, STAY; Shareholders are Encouraged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / May 11, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: EQT Corporation (NYSE:EQT) concerning potential... 
From Halper Sadeh LLP
Via AccessWire
Topics Fraud
Exposures Legal
MEREDITH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Meredith Corporation - MDP
From Kahn Swick & Foti, LLC
Via Business Wire
SHAREHOLDER ALERT: HALPER SADEH LLP INVESTIGATES MEREDITH CORPORATION – MDP
From Halper Sadeh LLP
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.